Fractyl Health, Inc. (GUTS) vs Kalaris Therapeutics Inc (KLRS)
A side-by-side comparison of Fractyl Health, Inc. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GUTS
Fractyl Health, Inc.
$4.47HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
KLRS
Kalaris Therapeutics Inc
$2.90HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — GUTS vs KLRS
growth of $100 · dividends reinvested · last 3yGUTS -97.0% (-69.1%/yr)KLRS -99.2% (-80.3%/yr)GUTS compounded faster over this window
GUTS KLRS
GUTS vs KLRS: by the numbers
- •KLRS is the larger company ($63M vs $59M market cap).
Metrics side by side
Valuation
| Metric | GUTS | KLRS |
|---|---|---|
| P/B ratio | N/A | 1.10 |
Profitability
| Metric | GUTS | KLRS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -76.75% |
| ROIC | -129.67% | -52.40% |
Growth (annualized)
| Metric | GUTS | KLRS |
|---|---|---|
| Total return CAGR (5Y) | N/A | -81.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.